GEHC Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

66.450

Open

65.918

VWAP

65.32

Vol

3.62M

Mkt Cap

29.52B

Low

64.620

Amount

236.73M

EV/EBITDA(TTM)

10.86

Total Shares

454.89M

37.64B

EV/OCF(TTM)

18.58

P/S(TTM)

1.41

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Events Timeline

(ET)

2026-06-29

09:30:00

GE HealthCare Launches Allia Platform Upgrade Pathways

2026-06-04 (ET)

2026-06-04

08:10:00

GE HealthCare Receives FDA Clearance for MIM Contour ProtegeAI+ 2.0

2026-06-01 (ET)

2026-06-01

08:30:00

GE HealthCare Showcases New Nuclear Medicine Technologies and AI Workflows

2026-05-12 (ET)

2026-05-12

09:10:00

GE HealthCare Showcases AI Solutions at 2026 Radiotherapy Congress

News

8.0

06-30Newsfilter

GE HealthCare Declares Q2 2026 Cash Dividend

2.0

06-24NASDAQ.COM

Western Digital Shares Drop 4.4% Amid Nasdaq 100 Performance

4.5

06-23NASDAQ.COM

US Stocks Plunge Sharply, Tech Sector Hit Hard

4.5

06-23NASDAQ.COM

U.S. Stocks Plunge Sharply, Tech Sector Hit Hard

6.0

06-23CNBC

Major Rating Changes on Wall Street

4.5

06-05NASDAQ.COM

Analysis of JAVA Stock's 52-Week High and Low Points

13 Analyst Rating

Wall Street analysts forecast GEHC stock price to rise

8 Buy

5 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

80.00

Averages

92.25

High

105.00

Current: 0.000

Low

80.00

Averages

92.25

High

105.00

RBC Capital

Outperform

initiated

$80

AI Analysis

2026-06-23

Reason

RBC Capital

Price Target

$80

AI Analysis

2026-06-23

initiated

Outperform

Reason

RBC Capital initiated coverage of GE HealthCare with an Outperform rating and $80 price target. The firm sees an attractive risk/reward at current share levels. The company's increased research and development investments and commercial execution post its 2023 spin from General Electric is driving order momentum, the analyst tells investors in a research note. RBC believes GE HealthCare's "strong backlog" positions it for accelerated growth starting later in 2026.

Evercore ISI

Outperform

downgrade

$85 -> $80

2026-04-30

Reason

Evercore ISI

Price Target

$85 -> $80

2026-04-30

downgrade

Outperform

Reason

Evercore ISI lowered the firm's price target on GE HealthCare to $80 from $85 and keeps an Outperform rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for GEHC

Unlock Now

Valuation Metrics

The current forward P/E ratio for GE Healthcare Technologies Inc (GEHC.O) is 13.40, compared to its 5-year average forward P/E of 17.83. For a more detailed relative valuation and DCF analysis to assess GE Healthcare Technologies Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

17.83

Current PE

13.40

Overvalued PE

19.98

Undervalued PE

15.69

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

11.42

Current EV/EBITDA

12.10

Overvalued EV/EBITDA

12.93

Undervalued EV/EBITDA

9.92

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.70

Current PS

1.29

Overvalued PS

1.97

Undervalued PS

1.43

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

what should i buy

Intellectia · 41 candidates

Market Cap: >= 10.00BRegion: USMarket Cap Category: mega, largeNet Margin: >= 10.00Beta: ModerateRiskPe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%

Ticker

Name

Market Cap$

MSFT

Microsoft Corp

3.10T

Goldman Sachs Group Inc

277.81B

AXP

American Express Co

226.22B

BBVA

Banco Bilbao Vizcaya Argentaria SA

131.73B

AEM

Agnico Eagle Mines Ltd

108.41B

BMO

Bank of Montreal

108.32B

Show US

Intellectia · 35 candidates

Market Cap: >= 10.00BRegion: USBeta: ModerateRiskPe Ttm: 5 - 30Return On Equity: >= 10.0%Is Index Component: GSPC, NDX

Ticker

Name

Market Cap$

MSFT

Microsoft Corp

3.10T

Home Depot Inc

349.60B

Goldman Sachs Group Inc

277.81B

AXP

American Express Co

226.22B

ADBE

Adobe Inc

100.50B

PNC

PNC Financial Services Group Inc

91.28B

je veux trader sur le nasdaq 100

Intellectia · 16 candidates

Price: $10.00 - $500.00Analyst Consensus: Strong Buy, Moderate BuyBeta: ModerateRiskIs Index Component: NDX

Ticker

Name

Market Cap$

AAPL

Apple Inc

3.76T

GOOG

Alphabet Inc

3.70T

MSFT

Microsoft Corp

2.98T

NFLX

Netflix Inc

324.56B

ISRG

Intuitive Surgical Inc

172.54B

PDD

PDD Holdings Inc

142.36B

NASDAQ100 stock with fairly or undervalue

Intellectia · 10 candidates

Analyst Consensus: Strong Buy, Moderate Buy, HoldPe Ttm: 8 - 22P/B Ratio: <= 4.00Is Index Component: NDXEv Ebitda: <= 15

Ticker

Name

Market Cap$

FANG

Diamondback Energy Inc

44.13B

PDD

PDD Holdings Inc

152.56B

PYPL

PayPal Holdings Inc

53.15B

BIIB

Biogen Inc

25.32B

TMUS

T-Mobile US Inc

211.11B

CTSH

Cognizant Technology Solutions Corp

41.28B

how do i create a customized screener

Intellectia · 94 candidates

Market Cap: >= 5.00BMarket Cap Category: large, midNet Margin: >= 5.00Beta: ModerateRiskPe Ttm: 10 - 30Return On Equity: >= 10.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

PDD

PDD Holdings Inc

150.37B

BBVA

Banco Bilbao Vizcaya Argentaria SA

141.76B

AEM

Agnico Eagle Mines Ltd

103.10B

BMO

Bank of Montreal

96.25B

PNC

PNC Financial Services Group Inc

91.17B

USB

US Bancorp

86.26B

show me stocks that have beta =0.8 Alfa =+5

Intellectia · 25 candidates

Market Cap: 20.00B - 50.00BBeta: ModerateRiskWeekly Average Turnover: >= 1,000,000Pe Ttm: <= 20

Ticker

Name

Market Cap$

DHI

D.R. Horton Inc

45.93B

DAL

Delta Air Lines Inc

45.02B

KGC

Kinross Gold Corp

43.05B

Estee Lauder Companies Inc

42.48B

JD.com Inc

41.25B

TCOM

Trip.com Group Ltd

40.50B

Whales Holding GEHC

Armistice Capital LLC

Bellevue Asset Management AG

Sofinnova Investments, Inc.

Castle Hook Partners LP

D1 Capital Partners L.P.

Sound Shore Management, Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is GE Healthcare Technologies Inc (GEHC) stock price today?

The current price of GEHC is 64.89 USD — it has increased 0.08

What is GE Healthcare Technologies Inc (GEHC)'s business?

What is the price predicton of GEHC Stock?

Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is92.25 USD with a low forecast of 80.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.